Since Coronavirus, there has been a lull in orthopedic IPOs', but the lull may be over next year.
First let's look back at the last 5 IPOs for reference and understand their terrible stock performance over the last 4 year (as of YE 2024)
May 2023 - Monogram Orthopaedics (80% drop in stock price, $13.50 to $2.66 to date)
October 2021 - Bone Biologics (99+% drop in stock price, $1099.20 to $1.12 to date)
April 2021 - Treace Medical Concepts (80% drop in stock price, $25.53 to $7.50 to date)
February 2021 - Bioventus (36% drop in stock price, $17.22 to $11.03 to date)
October 2020 - Paragon 28...
